Document Detail

Bronchodilators in Heart Failure Patients With COPD: Is It Time for a Clinical Trial?
MedLine Citation:
PMID:  22555273     Owner:  NLM     Status:  In-Data-Review    
Chronic heart failure (HF) and chronic obstructive pulmonary disease (COPD) commonly coexist, and patients with both diseases fare worse than those with either disease alone. Several factors may contribute to worse outcomes, including an increased burden of care related to greater disease complexity, an overlap of symptoms resulting in misapplication of therapy, and the adverse effects of treatment for one disease on the symptoms and outcomes related to the other. For example, there are conflicting data about the cardiovascular risks of bronchodilators in HF patients who may experience worse outcomes with inhaled beta-2 agonists via arrhythmogenesis, ischemia, and/or attenuation of beta-blocker benefits. In contrast, the long-acting anticholinergic class of bronchodilators has a more reassuring safety profile. Anticholinergic bronchodilators may be the preferred first-line agents for COPD patients with comorbid HF, yet data supporting these recommendations are limited. Therapeutic trials in COPD patients have generally excluded patients with significant HF and vice-versa. This paper reviews bronchodilator therapy in HF and proposes a randomized trial designed to enroll patients with significant COPD and HF to determine the risks and/or benefits of adding a long-acting beta-2 agonist to patients currently taking a long-acting anticholinergic agent.
Robert J Mentz; Mona Fiuzat; Monica Kraft; Joann Lindenfeld; Christopher M O'Connor
Related Documents :
22522723 - A nurse-led ocular oncology clinic in liverpool: results of a 6-month trial.
22494133 - Case 1-2012: a man with persistent ulcers on the hands.
9348043 - Establishing an approach to syncope in the emergency department.
Publication Detail:
Type:  Journal Article     Date:  2012-03-10
Journal Detail:
Title:  Journal of cardiac failure     Volume:  18     ISSN:  1532-8414     ISO Abbreviation:  J. Card. Fail.     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-05-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9442138     Medline TA:  J Card Fail     Country:  United States    
Other Details:
Languages:  eng     Pagination:  413-22     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
Division of Cardiology, Department of Medicine, Duke Clinical Research Institute and Duke University Medical Center, Durham, North Carolina.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Septal Rebound Stretch is a Strong Predictor of Outcome After Cardiac Resynchronization Therapy.
Next Document:  Ventricular Arrhythmias are Related to the Presence of Autoantibodies With Adrenergic Activity in Ch...